-+ 0.00%
-+ 0.00%
-+ 0.00%
Novax’s Apohem appoints Therese Kempe CEO, replacing Gustav Hasselgren
Share
Listen to the news
Novax’s Apohem appoints Therese Kempe CEO, replacing Gustav Hasselgren
  • Novax named Therese Kempe CEO of online pharmacy Apohem, effective today, replacing Gustav Hasselgren.
  • Kempe has been Apohem’s chief marketing officer since 2021, previously holding senior roles at Klarna, Procter & Gamble.
  • Hasselgren is leaving Apohem to take a new CEO role, ending a tenure that began in March 2019.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novax AB published the original content used to generate this news brief on September 17, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending